Hot Features
Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
Reneo Pharmaceuticals Inc is a clinical stage pharmaceutical company. It is focused on the development of therapies for patients with rare genetic mitochondrial diseases, which are often associated with the inability of mitochondria to produce adenosine triphosphate (ATP). The company is developing ... Reneo Pharmaceuticals Inc is a clinical stage pharmaceutical company. It is focused on the development of therapies for patients with rare genetic mitochondrial diseases, which are often associated with the inability of mitochondria to produce adenosine triphosphate (ATP). The company is developing REN001 to modulate genes critical to metabolism and generation of ATP, which is the primary source of energy for cellular processes. Mehr anzeigen
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0 | 0 | 18.2 | 18.2 | 18.2 | 0 | 0 | CS |
| 4 | 0 | 0 | 18.2 | 18.2 | 18.2 | 0 | 0 | CS |
| 12 | 0 | 0 | 18.2 | 18.2 | 18.2 | 0 | 0 | CS |
| 26 | 3.2 | 21.3333333333 | 15 | 19 | 13.5 | 29164 | 15.97088103 | CS |
| 52 | 1.7 | 10.303030303 | 16.5 | 19.3 | 12.501 | 108475 | 15.90720381 | CS |
| 156 | -16.2 | -47.0930232558 | 34.4 | 112.95 | 9.801 | 185393 | 29.27400372 | CS |
| 260 | -134.8 | -88.1045751634 | 153 | 168.3 | 9.801 | 156833 | 35.91555678 | CS |
| Keine Diskussionen Gefunden. |
| Neuen Thread Erstellen |
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
